NCT06128421|Unknown
Loading search results
Sponsor study identifier
interventional
60
1 country
1
Study Start
November 23, 2023
Actual (reported)Primary Completion
April 30, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
October 31, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
This study aims to investigate the safety and efficacy of individual nutrition support for treating hepatitis b virus(HBV) related acute-on-chronic liver failure patients at nutrition risk
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 31, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 6, 2023
Actual (reported)November 13, 2023
Actual (reported)November 23, 2023
Actual (reported)April 30, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
October 31, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Transplant free survival at 30 days
30 days
Transplant free survival at 90 days
90 days
L3-SMI as a marker of muscle mass
30 days, 90days
Grip as markers of muscle strength
30 days, 90days
Short Physical Performance Battery (SPPB) as markers of physical performance
30 days, 90 days
Improvement in quality of life
30 days, 90days
length of hospital stay
days in the hospital within index hospitalisation and within the 30 days of follow up measured by patient interview and medical chart review
30 patients will receive dietary counseling and individual nutrition support treatment based on Oral nutrition supplements and supplemented by parenteral nutrition.
30 patients will receive standard care food provided by the hospital kitchen according to their ability and desire, standard care food provided by the hospital kitchen.
Nutritional products and route（oral, parenteral）is possible to reach goals
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, 510630, China
Li Z, Luo Q, Wang P, Wang L, Zheng X, Zhang Y, Xu W, Peng L. Efficacy and safety of individual nutrition support in patients with hepatitis B virus-related acute-on-chronic liver failure at nutrition risk: a study protocol for a randomised controlled clinical trial. BMJ Open. 2024 Dec 9;14(12):e088832. doi: 10.1136/bmjopen-2024-088832.
First Submitted
November 6, 2023
First Posted
November 13, 2023
Study Start
November 23, 2023
Actual (reported)Primary Completion
April 30, 2024
Estimated (date passed)Biological Assessment of Clinical Nutrition and Its Application
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
October 31, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
January 25, 2024
Record last verified: 2024-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: